4 min read
Allergan, Inc. (NYSE:AGN) announced Friday the United States Food and Drug Administration (FDA) has approved a fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic. The newly approved assay will be implemented immediately for release of product for sale in the United States. Allergan estimates that use of the new assay will reduce the use of animal-based assay testing for BOTOX® and BOTOX® Cosmetic by up to 95 percent or more over the next three years, as other regulatory agencies around the world approve this new assay. The new assay is the first to be developed and approved for any botulinum neurotoxin currently available worldwide, and is specifically applicable to Allergan’s botulinum toxin type A product. Read More
- Published in Announcements
1 min read
The Professional Beauty Association (PBA) and National Cosmetology Association (NCA) are pleased to announce steady membership retention and growth in 2010. Comparing 2009 to 2010 year-end results, PBA’s Manufacturer and Distributor sections experienced exceptional results with double-digit growth at 19 percent and 20 percent respectively. PBA’s Salon/Spa section reported a two percent increase, which is ... Read More
- Published in Announcements
1 min read
Cosmetic Bootcamp, LLC. is pleased to announce the launch of its comprehensive aesthetic textbook, “The Cosmetic Bootcamp Primer (Informa).” This book contains chapters written by a variety of different specialties and in addition to the outstanding medical information also contains chapters on practice management as well as an instructional DVD. The Cosmetic Bootcamp Summer meeting, ... Read More
- Published in Announcements
